ZYPHORE THERAPEUTICS Trademark

Trademark Overview

On Friday, August 22, 2025, a trademark application was filed for ZYPHORE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ZYPHORE THERAPEUTICS trademark a serial number of 99352357. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, August 22, 2025. This trademark is owned by Zyphore Therapeutics, Inc.. The ZYPHORE THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Enzymes for medical purposes; engineered enzymes for medical purposes; enzyme substrates for medical purposes; therapeutic pharmaceuticals for the treatment and prevention of autoimmune diseases, cardiovascular diseases, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genitourinary diseases and disorders, genetic diseases and disorders, infectious diseases, inflammation-related diseases and disorders, kidney diseases, liver diseases, hepatological diseases, respiratory diseases, metabolic diseases and disorders, ophthalmic diseases, musculoskeletal disorders, rare muscle diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, immune system diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, cardiopulmonary diseases and disorders, bone growth disorders, skin disorders and diseases, psychiatric disorders and diseases, sexual dysfunction, hormonal disorders, arthritis, canc...

Enzyme preparations for use in the medical industry; enzyme stabilizers; enzyme substrates for scientific purposes.

Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; drug discovery services; development of pharmaceutical and therapeutic preparations and medicines; research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of autoimmune diseases, cardiovascular diseases, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genitourinary diseases and disorders, genetic diseases and disorders, infectious diseases, inflammation-related diseases and disorders, kidney diseases, liver diseases, hepatological diseases, respiratory diseases, metabolic diseases and disorders, ophthalmic diseases, musculoskeletal disorders, rare muscle diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, immune system diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, cardiopulmonary diseases a...
zyphore therapeutics

General Information

Serial Number99352357
Word MarkZYPHORE THERAPEUTICS
Filing DateFriday, August 22, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, August 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesEnzymes for medical purposes; engineered enzymes for medical purposes; enzyme substrates for medical purposes; therapeutic pharmaceuticals for the treatment and prevention of autoimmune diseases, cardiovascular diseases, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genitourinary diseases and disorders, genetic diseases and disorders, infectious diseases, inflammation-related diseases and disorders, kidney diseases, liver diseases, hepatological diseases, respiratory diseases, metabolic diseases and disorders, ophthalmic diseases, musculoskeletal disorders, rare muscle diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, immune system diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, cardiopulmonary diseases and disorders, bone growth disorders, skin disorders and diseases, psychiatric disorders and diseases, sexual dysfunction, hormonal disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations for the treatment and prevention of autoimmune diseases, cardiovascular diseases, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genitourinary diseases and disorders, genetic diseases and disorders, infectious diseases, inflammation-related diseases and disorders, kidney diseases, liver diseases, hepatological diseases, respiratory diseases, metabolic diseases and disorders, ophthalmic diseases, musculoskeletal disorders, rare muscle diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, immune system diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, cardiopulmonary diseases and disorders, bone growth disorders, skin disorders and diseases, psychiatric disorders and diseases, sexual dysfunction, hormonal disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; drug delivery agents that facilitate delivery and efficacy of pharmaceuticals, namely, drug delivery agents consisting of enzymes that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical and biological preparations for delivering therapeutic agents, namely, enzymes for the treatment of autoimmune diseases, cardiovascular diseases, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genitourinary diseases and disorders, genetic diseases and disorders, infectious diseases, inflammation-related diseases and disorders, kidney diseases, liver diseases, hepatological diseases, respiratory diseases, metabolic diseases and disorders, ophthalmic diseases, musculoskeletal disorders, rare muscle diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, immune system diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, cardiopulmonary diseases and disorders, bone growth disorders, skin disorders and diseases, psychiatric disorders and diseases, sexual dysfunction, hormonal disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; drug carriers for medical use, namely, drug delivery agents that facilitate the delivery of pharmaceutical preparations for delivering drugs to human cells, tissues and organs.
Goods and ServicesEnzyme preparations for use in the medical industry; enzyme stabilizers; enzyme substrates for scientific purposes.
Goods and ServicesProviding medical and scientific research information in the fields of pharmaceuticals and biotechnology; drug discovery services; development of pharmaceutical and therapeutic preparations and medicines; research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of autoimmune diseases, cardiovascular diseases, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genitourinary diseases and disorders, genetic diseases and disorders, infectious diseases, inflammation-related diseases and disorders, kidney diseases, liver diseases, hepatological diseases, respiratory diseases, metabolic diseases and disorders, ophthalmic diseases, musculoskeletal disorders, rare muscle diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, immune system diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, cardiopulmonary diseases and disorders, bone growth disorders, skin disorders and diseases, psychiatric disorders and diseases, sexual dysfunction, hormonal disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; research and development in the field of biotechnology; medical and scientific research in the field of autoimmune diseases, cardiovascular diseases, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genitourinary diseases and disorders, genetic diseases and disorders, infectious diseases, inflammation-related diseases and disorders, kidney diseases, liver diseases, hepatological diseases, respiratory diseases, metabolic diseases and disorders, ophthalmic diseases, musculoskeletal disorders, rare muscle diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, immune system diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, cardiopulmonary diseases and disorders, bone growth disorders, skin disorders and diseases, psychiatric disorders and diseases, sexual dysfunction, hormonal disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes.

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, August 22, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 22, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 22, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZyphore Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Friday, August 22, 2025NEW APPLICATION ENTERED
Friday, August 22, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

therapeutics zyphore diseases disorders medical system purposes enzyme research development neurological immune